{"id":41535,"date":"2021-10-31T07:13:42","date_gmt":"2021-10-31T07:13:42","guid":{"rendered":"https:\/\/i-base.info\/htb\/?p=41535"},"modified":"2021-11-01T16:02:06","modified_gmt":"2021-11-01T16:02:06","slug":"sanofi-reports-phase-1-2-mrna-results-but-withdraws-from-further-covid19-vaccines","status":"publish","type":"post","link":"https:\/\/i-base.info\/htb\/41535","title":{"rendered":"Sanofi reports phase 1\/2 mRNA results but withdraws from further COVID19 vaccines"},"content":{"rendered":"<div><strong><span lang=\"EN-US\">Simon Collins, HIV i-Base<\/span><\/strong><\/div>\n<div>\n<p class=\"HTBBODYtext\"><strong><span lang=\"EN-US\"><img loading=\"lazy\" decoding=\"async\" class=\" alignright\" src=\"https:\/\/i-base.info\/wp-content\/uploads\/2020\/03\/COVID-19-graphic.png\" width=\"231\" height=\"142\" \/>Positive interim results generated significant antibody responses at all studied doses, as proof of concept. <\/span><\/strong><\/p>\n<p class=\"HTBBODYtext\"><span lang=\"EN-US\">However, clinical efficacy results would require phase 3 studies over the next two years. Instead the company plan to withdraw from further COVID vaccine development and use mRNA technology for vaccines against influenza.<\/span><\/p>\n<\/div>\n<div>\n<p class=\"HTBreference-noindent\"><span lang=\"EN-US\">Refwewnce<\/span><\/p>\n<\/div>\n<div>\n<p class=\"HTBreference-noindent\"><span lang=\"EN-US\">Sanofi press statement. Sanofi announces positive phase 1\/2 study interim results for its first mRNA-based vaccine candidate. (28 September 2021).<br \/>\n<\/span><a href=\"https:\/\/www.sanofi.com\/en\/media-room\/press-releases\/2021\/2021-09-28-08-00-00-2304069\">https:\/\/www.sanofi.com\/en\/media-room\/press-releases\/2021\/2021-09-28-08-00-00-2304069<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Simon Collins, HIV i-Base Positive interim results generated significant antibody responses at all studied doses, as proof of concept. However, clinical efficacy results would require phase 3 studies over the next two years. Instead the company plan to withdraw from &hellip;<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[292,278],"tags":[],"class_list":["post-41535","post","type-post","status-publish","format-standard","hentry","category-covid-19-vaccine","category-covid-19"],"_links":{"self":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/41535","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/comments?post=41535"}],"version-history":[{"count":0,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/41535\/revisions"}],"wp:attachment":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/media?parent=41535"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/categories?post=41535"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/tags?post=41535"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}